PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: October 2009
Connect with a Click of the Mouse
Thanks to Google, Facebook, and Twitter, the Internet has become the e-Patient’s No. 1 destination for seeking health information, and industry was all “a tweet” about it at this year’s e-Patient Connections Conference.
More than 250 people were in attendance for the two-day event, which included pharma marketers, brand managers, and patient education specialists who shared [...]
Europe: Go Easy on Your Pharma Lobbyists
European pharmaceutical executives are sometimes heard to complain that their public affairs departments are not doing a good job for them, and that their industry associations are a waste of time and money.
A report published in Brussels earlier this month suggests that this judgment may be excessively harsh. Lobbyists for healthcare and pharmaceuticals score [...]
Posted in Europe, Regulatory Tagged European Union, healthcare, lobbyists, Pharma, regulation Leave a comment
AstraZeneca, BMS Announce Layoffs and Buyouts
AstraZeneca was the topic of conversation this week as word broke that the company is offering buyout deals to every member of its 5,500 US sales force.
“AstraZeneca is making changes to our sales force, which will be managed first by looking at vacancies and offering field sales employees the opportunity to self-identify whether they are [...]
Posted in Strategy Tagged AstraZeneca, Bristol Myers Squibb, Buyouts, Indiana, layoffs, New York City, Pfizer, Strategy, Wyeth 1 Comment
IMS Health is Looking for Suitors
IMS Health, on Tuesday, confirmed that its board of directors formed a committee to explore strategic alternatives, or as the Associated Press reported, “advanced discussions to sell the company.”
“There can be no assurance that the exploration of strategic alternatives will result in a transaction,” IMS stated in a release. “[IMS Health] stated that it does [...]
Posted in News, Strategy Tagged BC Partners, Board of directors, business, IMS Health, Investing, New York Stock Exchange, Private equity Leave a comment
If Not This, Then What? If Not Now, Then When?